Jieping Lei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jieping Lei has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Chen Wang
14Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
2 shared publicationsSinan Wu
China-Japan Friendship Hospital, Beijing, China
2 shared publicationsTing Yang
China-Japan Friendship Hospital, Beijing, China
2 shared publications- Chaozeng Si
Department of Information Management, China-Japan Friendship Hospital, Beijing 100029, China
1 shared publication - Chen Wang
China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
1 shared publication - Cunbo Jia
China-Japan Friendship Hospital, Beijing 100029, China
1 shared publication
Latest Publications
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA5980
Associations between CAT scales and comorbidities of anxiety and depression in spirometry-defined COPD patients: findings from the China Pulmonary Health Study
Background: Patients with chronic obstructive pulmonary disease (COPD) often have psychological comorbidities such as anxiety and depression, leading to worse consequences. However, the prevalence and impact of the psychological disorders were underestimated. Methods: Data were obtained from the China Pulmonary Health Study, the largest epidemiological survey on chronic respiratory diseases in China. Pulmonary and extra-pulmonary symptoms were assessed using the COPD Assessment Test (CAT), and anxiety and depression were determined using the Hospital Anxiety and Depression Scale. Logistic regression and receiver operating characteristic curve analyses were applied. Results: Among 3,641 spirometry-defined COPD patients, the prevalence of anxiety and depression was 11.07% (10.05-12.09%) and 14.23% (13.09-15.36%), respectively. Female gender, rural residence, unemployment, lower family income, total CAT score and scores of pulmonary and extra-pulmonary symptom subscales of CAT were independently associated with increased prevalence of anxiety and/or depression in COPD patients. The optimal cut-off values of total CAT score were 9 (area under the curve: 0.637 [0.607-0.666]) and 7 (0.633 [0.607-0.659]) for anxiety and depression identification in all patients, respectively. Notably, the cut-off values were 7 (0.624 [0.582-0.665] and 0.616 [0.579-0.653] for anxiety and depression) for COPD patients in the rural area, whereas the values were 11 (0.652 [0.610-0.694] for anxiety) and 10 (0.654 [0.618-0.691] for depression) in the urban area. Conclusions: The findings highlighted the importance of early identification of anxiety and depression using CAT scales in COPD patients, especially in rural areas of China.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA5980
Associations between CAT scales and comorbidities of anxiety and depression in spirometry-defined COPD patients: findings from the China Pulmonary Health Study
Background: Patients with chronic obstructive pulmonary disease (COPD) often have psychological comorbidities such as anxiety and depression, leading to worse consequences. However, the prevalence and impact of the psychological disorders were underestimated. Methods: Data were obtained from the China Pulmonary Health Study, the largest epidemiological survey on chronic respiratory diseases in China. Pulmonary and extra-pulmonary symptoms were assessed using the COPD Assessment Test (CAT), and anxiety and depression were determined using the Hospital Anxiety and Depression Scale. Logistic regression and receiver operating characteristic curve analyses were applied. Results: Among 3,641 spirometry-defined COPD patients, the prevalence of anxiety and depression was 11.07% (10.05-12.09%) and 14.23% (13.09-15.36%), respectively. Female gender, rural residence, unemployment, lower family income, total CAT score and scores of pulmonary and extra-pulmonary symptom subscales of CAT were independently associated with increased prevalence of anxiety and/or depression in COPD patients. The optimal cut-off values of total CAT score were 9 (area under the curve: 0.637 [0.607-0.666]) and 7 (0.633 [0.607-0.659]) for anxiety and depression identification in all patients, respectively. Notably, the cut-off values were 7 (0.624 [0.582-0.665] and 0.616 [0.579-0.653] for anxiety and depression) for COPD patients in the rural area, whereas the values were 11 (0.652 [0.610-0.694] for anxiety) and 10 (0.654 [0.618-0.691] for depression) in the urban area. Conclusions: The findings highlighted the importance of early identification of anxiety and depression using CAT scales in COPD patients, especially in rural areas of China.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA1011
Prevalence and presentation of early stage of chronic obstructive pulmonary disease in China: a national cross-sectional study
Aims: To determine current prevalence and unique characteristics of individuals with chronic obstructive pulmonary disease (COPD) stage 0, early COPD, pre-COPD, and preserved ratio impaired spirometry (PRISm), young COPD, and mild COPD in general Chinese population. Methods: Data were obtained from the China Pulmonary Health study (2012-2015), a nationally representative cross-sectional investigation with 50,991 adults aged 20 years or older. Definitions of disease status were consistent with the latest 2023 GOLD criteria. Results: The age-adjusted prevalence of COPD stage 0, early COPD, pre-COPD, PRISm, young COPD, and mild COPD were 13.44%, 1.33%, 9.54%, 4.81%, 2.41%, and 4.04%, respectively. COPD stage 0 and pre-COPD presented with higher burdens of symptoms (i.e. cough, sputum, wheeze, and dyspnea), experienced more exacerbations, and harbored multiple comorbidities (e.g. rhinitis or allergic rhinitis, chronic bronchitis, cardiovascular disease, gastroesophageal reflux disease, depression, anxiety, anemia, periodontitis, etc.). Particularly, pre-COPD exhibited more small airway dysfunction. PRISm presented with lower post-bronchodilator FEV1%pred values. Young and mild COPD had lower pre- and post-bronchodilator FEV1/FVC ratios, and more reversibilities. Over the six subgroups of population, less than 12% ever took pulmonary function test; less than 1% reported a previously diagnosed COPD; less than 15% received pharmaceutical treatment and/or oxygen therapy. Conclusions: Prevalence and presentation are varied with different criteria of early stage of disease; more attention, better management. and further research should be paid on these individuals.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA1011
Prevalence and presentation of early stage of chronic obstructive pulmonary disease in China: a national cross-sectional study
Aims: To determine current prevalence and unique characteristics of individuals with chronic obstructive pulmonary disease (COPD) stage 0, early COPD, pre-COPD, and preserved ratio impaired spirometry (PRISm), young COPD, and mild COPD in general Chinese population. Methods: Data were obtained from the China Pulmonary Health study (2012-2015), a nationally representative cross-sectional investigation with 50,991 adults aged 20 years or older. Definitions of disease status were consistent with the latest 2023 GOLD criteria. Results: The age-adjusted prevalence of COPD stage 0, early COPD, pre-COPD, PRISm, young COPD, and mild COPD were 13.44%, 1.33%, 9.54%, 4.81%, 2.41%, and 4.04%, respectively. COPD stage 0 and pre-COPD presented with higher burdens of symptoms (i.e. cough, sputum, wheeze, and dyspnea), experienced more exacerbations, and harbored multiple comorbidities (e.g. rhinitis or allergic rhinitis, chronic bronchitis, cardiovascular disease, gastroesophageal reflux disease, depression, anxiety, anemia, periodontitis, etc.). Particularly, pre-COPD exhibited more small airway dysfunction. PRISm presented with lower post-bronchodilator FEV1%pred values. Young and mild COPD had lower pre- and post-bronchodilator FEV1/FVC ratios, and more reversibilities. Over the six subgroups of population, less than 12% ever took pulmonary function test; less than 1% reported a previously diagnosed COPD; less than 15% received pharmaceutical treatment and/or oxygen therapy. Conclusions: Prevalence and presentation are varied with different criteria of early stage of disease; more attention, better management. and further research should be paid on these individuals.
- Open Access
- 25 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (17) , 4997
Assessment of the Effect on Thromboprophylaxis with Multifaceted Quality Improvement Intervention based on Clinical Decision Support System in Hospitalized Patients: A Pilot Study
Background: To explore the feasibility and effectiveness of multifaceted quality improvement intervention based on the clinical decision support system (CDSS) in VTE prophylaxis in hospitalized patients. Methods: A randomized, department-based clinical trial was conducted in the department of respiratory and critical care medicine, orthopedic, and general surgery wards. Patients aged ≥18 years, without VTE in admission, were allocated to the intervention group and received regular care combined with multifaceted quality improvement intervention based on CDSS during hospitalization. VTE prophylaxis rate and the occurrence of hospital-associated VTE events were analyzed as primary and secondary outcomes. Results: A total of 3644 eligible residents were enrolled in this trial. With the implementation of the multifaceted quality improvement intervention based on the CDSS, the VTE prophylaxis rate of the intervention group increased from 22.93% to 34.56% (p < 0.001), and the incidence of HA-VTE events increased from 0.49% to 1.00% (p = 0.366). In the nonintervention group, the VTE prophylaxis rate increased from 24.49% to 27.90% (p = 0.091), and the incidence of HA-VTE events increased from 0.47% to 2.02% (p = 0.001). Conclusions: Multifaceted quality improvement intervention based on the CDSS strategy is feasible and expected to facilitate implementation of the recommended VTE prophylaxis strategies and reduce the incidence of HA-VTE in hospital. However, it is necessary to conduct more multicenter clinical trials in the future to provide more reliable real-world evidence.
- 25 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (17) , 4997
Open AccessAssessment of the Effect on Thromboprophylaxis with Multifaceted Quality Improvement Intervention based on Clinical Decision Support System in Hospitalized Patients: A Pilot Study
Background: To explore the feasibility and effectiveness of multifaceted quality improvement intervention based on the clinical decision support system (CDSS) in VTE prophylaxis in hospitalized patients. Methods: A randomized, department-based clinical trial was conducted in the department of respiratory and critical care medicine, orthopedic, and general surgery wards. Patients aged ≥18 years, without VTE in admission, were allocated to the intervention group and received regular care combined with multifaceted quality improvement intervention based on CDSS during hospitalization. VTE prophylaxis rate and the occurrence of hospital-associated VTE events were analyzed as primary and secondary outcomes. Results: A total of 3644 eligible residents were enrolled in this trial. With the implementation of the multifaceted quality improvement intervention based on the CDSS, the VTE prophylaxis rate of the intervention group increased from 22.93% to 34.56% (p < 0.001), and the incidence of HA-VTE events increased from 0.49% to 1.00% (p = 0.366). In the nonintervention group, the VTE prophylaxis rate increased from 24.49% to 27.90% (p = 0.091), and the incidence of HA-VTE events increased from 0.47% to 2.02% (p = 0.001). Conclusions: Multifaceted quality improvement intervention based on the CDSS strategy is feasible and expected to facilitate implementation of the recommended VTE prophylaxis strategies and reduce the incidence of HA-VTE in hospital. However, it is necessary to conduct more multicenter clinical trials in the future to provide more reliable real-world evidence.